Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Invested Capital (2016 - 2025)

Historic Invested Capital for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $3.2 billion.

  • Surgery Partners' Invested Capital rose 111.55% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 111.55%. This contributed to the annual value of $6.6 billion for FY2024, which is 1306.37% up from last year.
  • Per Surgery Partners' latest filing, its Invested Capital stood at $3.2 billion for Q3 2025, which was up 111.55% from $3.3 billion recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Invested Capital peaked at $6.6 billion during Q4 2024, and registered a low of $2.1 billion during Q1 2022.
  • For the 5-year period, Surgery Partners' Invested Capital averaged around $3.5 billion, with its median value being $3.1 billion (2024).
  • Per our database at Business Quant, Surgery Partners' Invested Capital surged by 10350.61% in 2021 and then plummeted by 3120.86% in 2022.
  • Over the past 5 years, Surgery Partners' Invested Capital (Quarter) stood at $4.9 billion in 2021, then increased by 13.13% to $5.6 billion in 2022, then grew by 4.72% to $5.8 billion in 2023, then grew by 13.06% to $6.6 billion in 2024, then crashed by 50.84% to $3.2 billion in 2025.
  • Its Invested Capital stands at $3.2 billion for Q3 2025, versus $3.3 billion for Q2 2025 and $3.3 billion for Q1 2025.